News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Related Content
Trending on PharmExec
1
Moonwalk Biosciences Closes $70 Million Series B
2
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
3
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5